Anavex Life Sciences Corp (AVXL)

[tradeherpete]

That’s the thing isn’t it? A2-73 just does what it does and our blanket covers up lots of little messes. AD being one that pays the bills so very fortunate for us it improves those patients lives.

So there's a few typo's in the chimps retelling of the stories. They are chimps. What did you expect?

George Perry, PhD, Dean and Professor at the University of Texas at San Antonio and Editor-in Chief of the Journal of Alzheimer’s Disease, commented;

“In addition to the very encouraging results, which point to the therapeutic potential of targeting cellular homeostasis in a complex CNS disease like Alzheimer’s, this trial has been intelligently designed as a highly informative study, looking unprejudiced at all potential relationships and hence allowing to learn from all correlations of the now available pool of data, in order to execute subsequent trials with much more relevant information at hand.”

It's really hard to imagine it getting any better than this.

imo